BURBANK, Calif., Feb. 21, 2006 (PRIMEZONE) -- Imaging3(tm), Inc., (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, reports that the company has been featured in the industry trade e-zine, "Aunt Minnie.com". Based on a lengthy interview with the company's CEO, Mr. Dean Janes, at the Radiological Society of North America trade show in Chicago, the article profiles Imaging3's breakthrough new product, the Dominion(tm).
The article effectively communicates Imaging3's value proposition by noting the benefits of the Dominion product over standard imaging devices such as fluoroscopy or CT scans:
"You can see multiple planes simultaneously, and those are being
updated simultaneously," he said. "Standard fluoro is 30 fps,
which works out to 200 msec per frame or less. That is what we
are giving (physicians), but we're doing it in real-time in
three dimensions, so they don't have to reposition the patient.
They can now see the side, back, and front view simultaneously."
"Imaging3 hopes that Dominion's real-time 3D capabilities will
give it great clinical flexibility that will make the system
suitable for use in a variety of applications throughout the
hospital. Providing image guidance for surgical intervention,
in particular in orthopedics, is one such use," Janes said.
"Orthopedics will be very large since you can visualize joints
in three dimensions," he said. "If it's in real-time, you can
see movement in three dimensions."
Noting that the relative portability of the device is a key feature that will benefit hospitals and clinics, the article continued:
Imaging3 also plans to make Dominion's mobility a selling point.
Both the O-device and the system's workstation cart are mounted
on wheels and can fit through a standard hospital door. The
system runs off standard 120-volt power.
The article also revealed that Imaging3 plans to install Dominion at beta sites this summer, and has a number of luminary sites lined up throughout the U.S. When the system is commercially available, Imaging3 hopes to offer the base model with real-time 3D capability at $180,000, with a device capable of CT emulation running $400,000. Dominion still requires Food and Drug Administration 510(k) clearance.
Noting that the Dominion is priced substantially below current CT and MRI devices, while providing three dimensional imaging in real time, the article concluded with the following comments.
Janes hopes the low price of the base model will be an incentive
for hospitals to buy multiple Dominion units to install at
various locations in the enterprise.
"Hospitals are trying to get the most value per dollar for
imaging equipment, and having flexibility and having a system
that can do multimodality cases is really important for them,"
Janes said. "We think it will help us sell more than just one
per facility. Really, a hospital will at least want two or three
-- one for the OR exclusively, one for trauma, and one for
interventional."
To read the complete article, visit: http://www.auntminnie.com/index.asp?Sec=sup&Sub=cto&Pag=dis&ItemId=69614
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.